Jonathan D. Clapp

5.7k total citations
16 papers, 962 citations indexed

About

Jonathan D. Clapp is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Jonathan D. Clapp has authored 16 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 2 papers in Otorhinolaryngology. Recurrent topics in Jonathan D. Clapp's work include Cancer-related cognitive impairment studies (7 papers), Cancer survivorship and care (6 papers) and Brain Metastases and Treatment (3 papers). Jonathan D. Clapp is often cited by papers focused on Cancer-related cognitive impairment studies (7 papers), Cancer survivorship and care (6 papers) and Brain Metastases and Treatment (3 papers). Jonathan D. Clapp collaborates with scholars based in United States, Spain and India. Jonathan D. Clapp's co-authors include Paul F. Pinsky, Jeanne S. Mandelblatt, George Luta, Christine D. Berg, Arti Hurria, Denise R. Aberle, P. M. Marcus, David A. Lynch, Ilana F. Gareen and Harvey Jay Cohen and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Jonathan D. Clapp

15 papers receiving 938 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan D. Clapp United States 12 613 436 109 102 101 16 962
Goulnar Kasymjanova Canada 18 501 0.8× 575 1.3× 33 0.3× 57 0.6× 43 0.4× 56 1.0k
Noam A. VanderWalde United States 16 242 0.4× 269 0.6× 149 1.4× 64 0.6× 44 0.4× 48 822
Raymond Woo-Jun Jang Canada 13 348 0.6× 445 1.0× 54 0.5× 86 0.8× 32 0.3× 65 959
Melissa Accordino United States 18 222 0.4× 445 1.0× 41 0.4× 60 0.6× 52 0.5× 98 905
Francesco Rosetti Italy 13 437 0.7× 640 1.5× 149 1.4× 30 0.3× 25 0.2× 23 1.1k
Inge R. Konings Netherlands 17 220 0.4× 453 1.0× 84 0.8× 30 0.3× 44 0.4× 42 1.0k
Belinda E. Kiely Australia 19 228 0.4× 538 1.2× 78 0.7× 94 0.9× 31 0.3× 81 1.0k
Kathryn Bylow United States 14 400 0.7× 367 0.8× 245 2.2× 37 0.4× 26 0.3× 38 890
Santi Barbera Italy 10 456 0.7× 632 1.4× 148 1.4× 38 0.4× 14 0.1× 17 978
Tina Hsu Canada 16 258 0.4× 492 1.1× 406 3.7× 69 0.7× 58 0.6× 60 1.1k

Countries citing papers authored by Jonathan D. Clapp

Since Specialization
Citations

This map shows the geographic impact of Jonathan D. Clapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan D. Clapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan D. Clapp more than expected).

Fields of papers citing papers by Jonathan D. Clapp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan D. Clapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan D. Clapp. The network helps show where Jonathan D. Clapp may publish in the future.

Co-authorship network of co-authors of Jonathan D. Clapp

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan D. Clapp. A scholar is included among the top collaborators of Jonathan D. Clapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan D. Clapp. Jonathan D. Clapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
O’Neill, Suzanne C., Kathryn L. Taylor, Jonathan D. Clapp, et al.. (2018). Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives. Journal of Health Communication. 23(7). 679–686. 7 indexed citations
2.
Clapp, Jonathan D., George Luta, Brent J. Small, et al.. (2018). The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates. Archives of Clinical Neuropsychology. 33(8). 956–963. 11 indexed citations
3.
Ferrandis, Estrella Durá, Jeanne S. Mandelblatt, Jonathan D. Clapp, et al.. (2017). Personality, coping, and social support as predictors of long‐term quality‐of‐life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance). Psycho-Oncology. 26(11). 1914–1921. 64 indexed citations
4.
Mandelblatt, Jeanne S., Ling Cai, George Luta, et al.. (2017). Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance). Breast Cancer Research and Treatment. 164(1). 107–117. 62 indexed citations
5.
Bluethmann, Shirley M., Catherine M. Alfano, Jonathan D. Clapp, et al.. (2017). Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance). Breast Cancer Research and Treatment. 165(3). 677–686. 14 indexed citations
6.
Kimmick, Gretchen, Brittny Major, Jonathan D. Clapp, et al.. (2017). Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Research and Treatment. 163(2). 391–398. 12 indexed citations
7.
Mandelblatt, Jeanne S., Jonathan D. Clapp, George Luta, et al.. (2016). Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. 122(22). 3555–3563. 68 indexed citations
8.
Mandelblatt, Jeanne S., Robert A. Stern, George Luta, et al.. (2014). Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?. PMC. 1 indexed citations
9.
Faul, Leigh Anne, George Luta, Vanessa B. Sheppard, et al.. (2014). Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901. Journal of Cancer Survivorship. 8(4). 627–637. 32 indexed citations
10.
Sheppard, Vanessa B., Leigh Anne Faul, George Luta, et al.. (2014). Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901. Journal of Clinical Oncology. 32(22). 2318–2327. 69 indexed citations
11.
Mandelblatt, Jeanne S., Robert A. Stern, George Luta, et al.. (2014). Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?. Journal of Clinical Oncology. 32(18). 1909–1918. 122 indexed citations
12.
Aberle, Denise R., Christine D. Berg, Jonathan D. Clapp, et al.. (2010). Baseline Characteristics of Participants in the Randomized National Lung Screening Trial. JNCI Journal of the National Cancer Institute. 102(23). 1771–1779. 227 indexed citations
13.
Croswell, Jennifer M., Barnett S. Kramer, Aimée R. Kreimer, et al.. (2009). Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening. The Annals of Family Medicine. 7(3). 212–222. 102 indexed citations
14.
Croswell, Jennifer M., Stuart G. Baker, Pamela M. Marcus, Jonathan D. Clapp, & Barnett S. Kramer. (2009). Cumulative risk for a false-positive test using low-dose computed tomography in lung cancer screening. Journal of Clinical Oncology. 27(18_suppl). CRA1502–CRA1502. 1 indexed citations
15.
Croswell, Jennifer M., et al.. (2009). Cumulative risk for a false-positive test using low-dose computed tomography in lung cancer screening. Journal of Clinical Oncology. 27(15_suppl). CRA1502–CRA1502.
16.
Levin, David L., E. David Crawford, Edward P. Gelmann, et al.. (2005). Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings From the Initial Screening Round of a Randomized Trial. JNCI Journal of the National Cancer Institute. 97(6). 433–438. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Goulnar Kasymjanova Breakdown of academic impact, for papers by Noam A. VanderWalde Breakdown of academic impact, for papers by Raymond Woo-Jun Jang Breakdown of academic impact, for papers by Melissa Accordino Breakdown of academic impact, for papers by Francesco Rosetti Breakdown of academic impact, for papers by Inge R. Konings Breakdown of academic impact, for papers by Belinda E. Kiely Breakdown of academic impact, for papers by Kathryn Bylow Breakdown of academic impact, for papers by Santi Barbera Breakdown of academic impact, for papers by Tina Hsu
Rankless by CCL
2026